{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:29:17Z","timestamp":1708734557024},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"LEO Pharma Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s13555-023-01093-w","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T07:02:22Z","timestamp":1706943742000},"page":"293-302","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Podcast on Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases"],"prefix":"10.1007","volume":"14","author":[{"given":"Lakshi M.","family":"Aldredge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston D.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Y.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,3]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","DOI":"10.17632\/dtfpr7fpnb.1","author":"VY Shi","year":"2022","unstructured":"Shi VY, Chamberlain W, Siegfried E, Kraff-Cooper C, Beckman K, Lio P, et\u00a0al. Supplementary material-practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: a review. Mendeley Data. 2022. https:\/\/doi.org\/10.17632\/dtfpr7fpnb.1.","journal-title":"Mendeley Data"},{"key":"1093_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.01.043","author":"VY Shi","year":"2023","unstructured":"Shi VY, Chamberlain W, Siegfried E, Kraff-Cooper C, Beckman K, Lio P, et\u00a0al. Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: a review. J Am Acad Dermatol. 2023. https:\/\/doi.org\/10.1016\/j.jaad.2023.01.043.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"1093_CR3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S Stander","year":"2021","unstructured":"Stander S. Atopic dermatitis. N Engl J Med. 2021;384(12):1136\u201343. https:\/\/doi.org\/10.1056\/NEJMra2023911.","journal-title":"N Engl J Med"},{"issue":"3","key":"1093_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et\u00a0al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008.","journal-title":"Ocul Surf"},{"issue":"3","key":"1093_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.iac.2010.06.004","volume":"30","author":"B Bielory","year":"2010","unstructured":"Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am. 2010;30(3):323\u201336. https:\/\/doi.org\/10.1016\/j.iac.2010.06.004.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"1093_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/1203475417743233","volume":"22","author":"M Gooderham","year":"2018","unstructured":"Gooderham M, McDonald J, Papp K. Diagnosis and management of conjunctivitis for the dermatologist. J Cutan Med Surg. 2018;22(2):200\u20136. https:\/\/doi.org\/10.1177\/1203475417743233.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"1093_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","volume":"66","author":"MS Sridhar","year":"2018","unstructured":"Sridhar MS. Anatomy of cornea and ocular surface. Indian J Ophthalmol. 2018;66(2):190\u20134. https:\/\/doi.org\/10.4103\/ijo.IJO_646_17.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"1093_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ophtha.2016.11.003","volume":"124","author":"PP Lee","year":"2017","unstructured":"Lee PP. Vision and public health: framing a purpose for our work. Ophthalmology. 2017;124(2):148\u201350. https:\/\/doi.org\/10.1016\/j.ophtha.2016.11.003.","journal-title":"Ophthalmology"},{"key":"1093_CR9","unstructured":"National Academies of Sciences E, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health. Making Eye Health a Population Health Imperative: Vision for Tomorrow. Washington (DC): National Academies Press (US); 2016"},{"issue":"6","key":"1093_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/icu.0000000000000532","volume":"29","author":"N Patel","year":"2018","unstructured":"Patel N, Venkateswaran N, Wang Z, Galor A. Ocular involvement in atopic disease: a review. Curr Opin Ophthalmol. 2018;29(6):576\u201381. https:\/\/doi.org\/10.1097\/icu.0000000000000532.","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"1093_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40268-019-00288-x","volume":"19","author":"G Agnihotri","year":"2019","unstructured":"Agnihotri G, Shi K, Lio PA. A clinician\u2019s guide to the recognition and management of dupilumab-associated conjunctivitis. Drugs R D. 2019;19(4):311\u20138. https:\/\/doi.org\/10.1007\/s40268-019-00288-x.","journal-title":"Drugs R D"},{"issue":"3","key":"1093_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/bjd.17869","volume":"181","author":"B Akinlade","year":"2019","unstructured":"Akinlade B, Guttman-Yassky E, de Bruin-Weller M, Simpson EL, Blauvelt A, Cork MJ, et\u00a0al. Conjunctivitis in dupilumab clinical trials. Br J Dermatol. 2019;181(3):459\u201373. https:\/\/doi.org\/10.1111\/bjd.17869.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1093_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaad.2020.08.051","volume":"84","author":"AS Halling","year":"2021","unstructured":"Halling AS, Loft N, Silverberg JI, Guttman-Yassky E, Thyssen JP. Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis. J Am Acad Dermatol. 2021;84(1):139\u201347. https:\/\/doi.org\/10.1016\/j.jaad.2020.08.051.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1093_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/ICO.0000000000002461","volume":"40","author":"A Bohner","year":"2021","unstructured":"Bohner A, Topham C, Strunck J, Haynes D, Brazil M, Clements J, et\u00a0al. Dupilumab-associated ocular surface disease: clinical characteristics, treatment, and follow-up. Cornea. 2021;40(5):584\u20139. https:\/\/doi.org\/10.1097\/ICO.0000000000002461.","journal-title":"Cornea"},{"issue":"118","key":"1093_CR15","first-page":"14","volume":"36","author":"S Sabherwal","year":"2023","unstructured":"Sabherwal S, Mohamed-Ahmed AHA. The impact of oral and systemic medications on the eye. Commun Eye Health. 2023;36(118):14\u20136.","journal-title":"Commun Eye Health"},{"issue":"3","key":"1093_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bjd.20810","volume":"186","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg A, Beck LA, de Bruin WM, Simpson EL, Imafuku S, Boguniewicz M, et\u00a0al. Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials. Br J Dermatol. 2022;186(3):453\u201365. https:\/\/doi.org\/10.1111\/bjd.20810.","journal-title":"Br J Dermatol"},{"issue":"12","key":"1093_CR17","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jamadermatol.2018.3427","volume":"154","author":"RM Levine","year":"2018","unstructured":"Levine RM, Tattersall IW, Gaudio PA, King BA. Cicatrizing blepharoconjunctivitis occurring during dupilumab treatment and a proposed algorithm for its management. JAMA Dermatol. 2018;154(12):1485\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2018.3427.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"1093_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.18502\/jovr.v15i3.7456","volume":"15","author":"AA Azari","year":"2020","unstructured":"Azari AA, Arabi A. Conjunctivitis: a systematic review. J Ophthalmic Vis Res. 2020;15(3):372\u201395. https:\/\/doi.org\/10.18502\/jovr.v15i3.7456.","journal-title":"J Ophthalmic Vis Res"},{"issue":"12","key":"1093_CR19","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1111\/all.15064","volume":"76","author":"DS Bakker","year":"2021","unstructured":"Bakker DS, Ter Linde JJM, Amini MM, Ariens LFM, van Luijk CM, de Bruin-Weller MS, et\u00a0al. Conjunctival inflammation in dupilumab-treated atopic dermatitis comprises a multicellular infiltrate with elevated T1\/T17 cytokines: a case series study. Allergy. 2021;76(12):3814\u20137. https:\/\/doi.org\/10.1111\/all.15064.","journal-title":"Allergy"},{"issue":"1","key":"1093_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40257-020-00577-1","volume":"22","author":"A Bansal","year":"2021","unstructured":"Bansal A, Simpson EL, Paller AS, Siegfried EC, Blauvelt A, de Bruin-Weller M, et\u00a0al. Conjunctivitis in dupilumab clinical trials for adolescents with atopic dermatitis or asthma. Am J Clin Dermatol. 2021;22(1):101\u201315. https:\/\/doi.org\/10.1007\/s40257-020-00577-1.","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"1093_CR21","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1111\/all.15326","volume":"77","author":"PM Hansen","year":"2022","unstructured":"Hansen PM, Tollenaere MAX, Hedengran A, Heegaard S, Amoudruz P, Ropke M, et\u00a0al. IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro. Allergy. 2022;77(8):2555\u20138. https:\/\/doi.org\/10.1111\/all.15326.","journal-title":"Allergy"},{"issue":"5","key":"1093_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/ph15050547","volume":"15","author":"BA Labib","year":"2022","unstructured":"Labib BA, Chigbu DI. Therapeutic targets in allergic conjunctivitis. Pharmaceuticals (Basel). 2022;15(5):547. https:\/\/doi.org\/10.3390\/ph15050547.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"1093_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41420-023-01511-0","volume":"9","author":"JH Ko","year":"2023","unstructured":"Ko JH, Kim S, Ryu JS, Song HJ, Oh JY. Interferon-gamma elicits the ocular surface pathology mimicking dry eye through direct modulation of resident corneal cells. Cell Death Discov. 2023;9(1):209. https:\/\/doi.org\/10.1038\/s41420-023-01511-0.","journal-title":"Cell Death Discov"},{"key":"1093_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2021.05.005","volume":"236","author":"MA Stepp","year":"2021","unstructured":"Stepp MA, Menko AS. Immune responses to injury and their links to eye disease. Transl Res. 2021;236:52\u201371. https:\/\/doi.org\/10.1016\/j.trsl.2021.05.005.","journal-title":"Transl Res"},{"issue":"7","key":"1093_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/09546634.2019.1605142","volume":"31","author":"A Gottlieb","year":"2020","unstructured":"Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists. J Dermatolog Treat. 2020;31(7):662\u201379. https:\/\/doi.org\/10.1080\/09546634.2019.1605142.","journal-title":"J Dermatolog Treat"},{"key":"1093_CR26","unstructured":"MedlinePlus. Conjunctivitis or pink eye. Medical Encyclopedia: Bethesda (MD): National Library of Medicine (US); 2022"},{"key":"1093_CR27","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.2147\/OPTH.S41358","volume":"7","author":"LM Rosin","year":"2013","unstructured":"Rosin LM, Bell NP. Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops. Clin Ophthalmol. 2013;7:2131\u20135. https:\/\/doi.org\/10.2147\/OPTH.S41358.","journal-title":"Clin Ophthalmol"},{"key":"1093_CR28","unstructured":"AAO. Part V: Ocular Pharmacology Chapter 16: Ocular Pharmacotherapeutics*. In: Brar VS, editor. 2020\u20132021 Basic and Clinical Science Course, Section 02: Fundamentals and Principles of Ophthalmology. American Academy of Ophthalmology; 2020"},{"issue":"5","key":"1093_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/09286586.2021.1971262","volume":"29","author":"VF Chan","year":"2022","unstructured":"Chan VF, Yong AC, Azuara-Blanco A, Gordon I, Safi S, Lingham G, et\u00a0al. A systematic review of clinical practice guidelines for infectious and non-infectious conjunctivitis. Ophthalmic Epidemiol. 2022;29(5):473\u201382. https:\/\/doi.org\/10.1080\/09286586.2021.1971262.","journal-title":"Ophthalmic Epidemiol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-01093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-01093-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-01093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:20:22Z","timestamp":1708712422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-01093-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-01093-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lakshi M. Aldredge is on the Board of Directors for the Society of Dermatology Nurse Practitioners and has served on Speakers\u2019 Bureaus, Advisory Boards, or as a consultant for the following companies: AbbVie, Arcutis Biotherapeutics, Bristol Myers Squibb, Boehringer Ingelheim, Dermavant Sciences, Inc., Eli Lilly and Company, Incyte Corporation, Janssen Pharmaceuticals, LEO Pharma, Novartis, Pfizer, Regeneron Pharmaceuticals, Sanofi, UCB. Winston D. Chamberlain is a medical advisor and\/or investigator for Aslan Pharmaceuticals, Beyeonics, Cambium, Kowa, LEO Pharma, Noveome Biotherapeutics, BrightStar Therapeutics, Oyster Point, Regeneron, Neumora and Pfizer. Vivian Y. Shi is on the board of directors for the Hidradenitis Suppurativa Foundation (HSF), an advisor for the National Eczema Association, is a stock shareholder of Learn Health, and has served as an advisory board member, investigator, speaker, and\/or received research funding from AbbVie, Altus Lab\/cQuell, Aristea Therapeutics, Boehringer Ingelheim, Burt\u2019s Bees, Dermira, Ely Lilly, Galderma, GPSkin, Incyte, Kiniksa, LEO Pharma, Menlo Therapeutics, MYOR, Novartis, Pfizer, Polyfins Techology, Regeneron, Sanofi Genzyme, Skin Actives Scientific, SUN Pharma, Target-PharmaSolutions, and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}